The results showed that complex Ru0 is much more effective in promoting in vitro cytotoxic effect on HER2+ and RH+/HER2− breast cancer cell lines than the reference metallodrugs cisplatin, carboplatin, or RAPTA–C [35]. Here, ERBB2 is linked to breast carcinoma.